Additionally, a CRISPR screen performed in chronic myeloid leukemia (CML) cells demonstrated that DCAF15 is a negative regulator of natural killer (NK) cell-mediated clearance of cancer cells74. Here, DCAF15 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.